AU Patent

AU2009325962A1 — Biomarkers for insulin sensitizer drug response

Assigned to IKFE Institut fur Klinische Forschung und Entwicklung GmbH · Expires 2011-07-28 · 15y expired

What this patent protects

The invention provides compositions and methods for determining insulin sensitizer drug response in a subject. The invention also provides compositions and methods for treating a subject according to insulin sensitizer drug response.

USPTO Abstract

The invention provides compositions and methods for determining insulin sensitizer drug response in a subject. The invention also provides compositions and methods for treating a subject according to insulin sensitizer drug response.

Drugs covered by this patent

Patent Metadata

Patent number
AU2009325962A1
Jurisdiction
AU
Classification
—
Expires
2011-07-28
Drug substance claim
No
Drug product claim
No
Assignee
IKFE Institut fur Klinische Forschung und Entwicklung GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.